Mereo BioPharma MREO
NASDAQ MREO
$0.29 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Depreciation & Amortization (CF) (2023 - 2026)

Updated

Mereo BioPharma's Depreciation & Amortization (CF) came in at $38,000 for Q2 2026, down 13.6% from $44,000 a year earlier and down 13.6% from the prior quarter.

Analysis

Mereo BioPharma (MREO) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Mereo BioPharma reported Depreciation & Amortization (CF) of $200,000, down 9.1% year-over-year; for FY2025, it came in at $200,000, up 39.9% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of -37.6% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $143,000 in FY2024 (-28.5%), $200,000 in FY2023 (-76.5%), $852,719 in FY2022 (-1.5%) and $865,423 in FY2021 (-59.0%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $38,000 (Q4 2024) to $100,000 (Q3 2024).
  • Year-over-year, Depreciation & Amortization (CF) increased in two of the last eight quarters, with an average decline of 7.6%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2025 (growth of 107.9%), and the weakest in Q3 2025 (a decline of 61.0%).
  • Business Quant data shows MREO's Depreciation & Amortization (CF) at $44,000 (Q1 2026), $79,000 (Q4 2025) and $39,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.62 Bn
10 Mereo BioPharma 46.31 Mn -103.60 Mn - 38,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38,000.00
Mar 31, 2026 44,000.00
Dec 31, 2025 79,000.00
Sep 30, 2025 39,000.00
Jun 30, 2025 44,000.00
Mar 31, 2025 38,000.00
Dec 31, 2024 38,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 41,000.00
Dec 31, 2023 71,000.00
Sep 30, 2023 100,000.00
Jun 30, 2023 100,000.00
Mar 31, 2023 42,000.00
API Access

Mereo BioPharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MREO&period=max&api_key=YOUR_API_KEY